The prescription of substitution drugs, such as methadone and buprenorphine, has become a mainstream, first-line treatment for opioid dependence, with around 700 000 of Europe’s 1.3 million problem opioid users receiving substitution treatment today. But a small minority of entrenched opioid users repeatedly fails to respond to interventions of this kind. Findings from international trials now suggest that the supervised use of medicinal heroin can be an effective second-line treatment for this small, and previously unresponsive, group. In this latest EMCDDA Insights report, experts describe the development as ‘an important clinical step forward’. The report provides the first state-of-the-art overview of research on the subject, examining the latest evidence and clinical experience in this area in Europe and beyond.
- A Double Dissociation Between Inattentive and Impulsive Traits, on Tasks of Visual Processing and Emotion Regulation
- Locating ‘Nos’ in the Dialectics of Instinct, Communication and Society
- Successful Practices for the Strategic Use of Political Parody and Satire: Lessons From the P6 Symposium and the 2012 Election Campaign
- Learning experiences and gains from continuing professional education and their applicability to work for Japanese government officials
- Social Work and Social Development: Perspectives From India and the United States, edited by Shweta Singh
Category Specific RSS